Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SYNGENE.NSthis companySyngene International Limited	₹436.90	49.54×	3.24×	4.2×	16.78×	18.0%	33.8%	14.1%	8.5%	6.5%	7.3%	3.9%	0.09×	-0.41×	10.79×	1.38×	0.3%	3	6.39	3	B
ANTHEM.NSAnthem Biosciences Ltd.	₹958.15	62.21×	12.1×	17.33×	43.89×	-76.6%	42.1%	32.9%	27.9%	19.5%	16.1%	1.9%	0.02×	-0.26×	101.5×	5.54×	0.0%	5	77.36	1	D+
CONCORDBIO.NSConcord Biotech Limited	₹596.80	41.1×	5.32×	10.16×	25.54×	-74.8%	41.9%	27.8%	24.7%	12.9%	10.7%	1.6%	0×	-0.03×	1,034.4×	7.39×	1.0%	3	30.82	3	B+
DCAL.NSDishman Carbogen Amcis Limited	₹167.10	20.9×	0.3×	0.69×	7.34×	-102.0%	25.2%	7.6%	3.3%	1.5%	1.9%	3.8%	0.46×	3.71×	1.28×	1.23×	0.0%	3	—	2	C
JUBLPHARMA.NSJubilant Pharmova Limited	₹966.00	32.46×	1.82×	1.56×	12.07×	-242.1%	30.1%	9.9%	4.8%	5.6%	4.0%	-3.4%	0.51×	1.85×	3.87×	1.62×	0.6%	5	—	2	C
NECLIFE.NSNectar Lifesciences Limited	₹10.25	-0.67×	0.34×	97.56×	-2.9×	-45.1%	-2936.3%	-95.1%	-14568.1%	-50.3%	-0.2%	-184.1%	0×	3.87×	-0.05×	8.4×	0.0%	3	—	2	C+
Peer median	—	32.46×	1.82×	10.16×	12.07×	-76.6%	30.1%	9.9%	4.8%	5.6%	4.0%	1.6%	0.02×	1.85×	3.87×	5.54×	0.0%	3	54.09	2	—